Stock Scorer

BioNTech SE (BNTX) · Insider trading

What BioNTech's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$83.81M
2 insiders, 100% under a plan
Net, 12 months
−$83.81M
bought less sold
Latest filing
2026-10-07
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2026-01 2026-04: $5.53M sold 2026-07 2026-09: $63.65M sold 2026-10: $14.64M sold
Bought Sold Largest month: $63.65M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Sahin UgurChief Executive Officer, 10% owner – $78.29M 24 2026-10-07 63,209
Poetting SierkChief Operating Officer – $5.53M 1 2026-04-22 –

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-10-07 Sahin UgurChief Executive Officer, 10% owner Saleplan 24,000 95.86 $2.30M 63,209 Form 4
2026-10-06 Sahin UgurChief Executive Officer, 10% owner Saleplan 21,000 96.81 $2.03M 87,209 Form 4
2026-10-05 Sahin UgurChief Executive Officer, 10% owner Saleplan 72,000 97.23 $7.00M 108,209 Form 4
2026-10-02 Sahin UgurChief Executive Officer, 10% owner Saleplan 17,000 96.72 $1.64M 180,209 Form 4
2026-10-01 Sahin UgurChief Executive Officer, 10% owner Saleplan 17,000 97.46 $1.66M 197,209 Form 4
2026-09-30 Sahin UgurChief Executive Officer, 10% owner Saleplan 32,000 98.12 $3.14M 214,209 Form 4
2026-09-29 Sahin UgurChief Executive Officer, 10% owner Saleplan 34,000 98.26 $3.34M 246,209 Form 4
2026-09-28 Sahin UgurChief Executive Officer, 10% owner Saleplan 34,000 98.47 $3.35M 280,209 Form 4
2026-09-25 Sahin UgurChief Executive Officer, 10% owner Saleplan 27,000 98.69 $2.66M 314,209 Form 4
2026-09-24 Sahin UgurChief Executive Officer, 10% owner Saleplan 39,000 98.99 $3.86M 341,209 Form 4
2026-09-23 Sahin UgurChief Executive Officer, 10% owner Saleplan 30,000 99.40 $2.98M 380,209 Form 4
2026-09-22 Sahin UgurChief Executive Officer, 10% owner Saleplan 46,000 100.72 $4.63M 410,209 Form 4
2026-09-21 Sahin UgurChief Executive Officer, 10% owner Saleplan 33,000 97.81 $3.23M 456,209 Form 4
2026-09-18 Sahin UgurChief Executive Officer, 10% owner Saleplan 30,000 96.22 $2.89M 489,209 Form 4
2026-09-17 Sahin UgurChief Executive Officer, 10% owner Saleplan 34,000 98.60 $3.35M 519,209 Form 4
2026-09-16 Sahin UgurChief Executive Officer, 10% owner Saleplan 15,000 96.09 $1.44M 553,209 Form 4
2026-09-15 Sahin UgurChief Executive Officer, 10% owner Saleplan 34,000 96.49 $3.28M 568,209 Form 4
2026-09-14 Sahin UgurChief Executive Officer, 10% owner Saleplan 41,000 99.45 $4.08M 602,209 Form 4
2026-09-11 Sahin UgurChief Executive Officer, 10% owner Saleplan 45,000 96.93 $4.36M 643,209 Form 4
2026-09-10 Sahin UgurChief Executive Officer, 10% owner Saleplan 20,500 96.31 $1.97M 688,209 Form 4
2026-09-09 Sahin UgurChief Executive Officer, 10% owner Saleplan 36,000 97.78 $3.52M 708,709 Form 4
2026-09-08 Sahin UgurChief Executive Officer, 10% owner Saleplan 37,000 99.20 $3.67M 744,709 Form 4
2026-09-04 Sahin UgurChief Executive Officer, 10% owner Saleplan 31,500 103.52 $3.26M 781,709 Form 4
2026-09-03 Sahin UgurChief Executive Officer, 10% owner Saleplan 45,000 102.85 $4.63M 813,209 Form 4
2026-04-22 Poetting SierkChief Operating Officer Saleplanindirect 50,000 110.56 $5.53M 399,387 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

BioNTech's scores and multiples ›